| Q37492797 | A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity |
| Q35323147 | A lower viral set point but little immunological impact after early treatment during primary HIV infection |
| Q36673915 | Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. |
| Q36223710 | Advances in understanding immunologic control of HIV infection |
| Q35923352 | Antigen-presenting cell modulation induces a memory response to p24 in peripheral blood leukocytes from human immunodeficiency virus-infected individuals |
| Q35136008 | Apoptosis as an HIV strategy to escape immune attack |
| Q36684398 | Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells. |
| Q90050621 | Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure |
| Q35101557 | CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells |
| Q45708636 | CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects |
| Q37327826 | CD4+ T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease |
| Q39280285 | CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes |
| Q34730855 | CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy |
| Q56935562 | CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals |
| Q34325840 | Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1. |
| Q44624338 | Cellular immune responses in human immunodeficiency virus (HIV)-1-infected children: is immune restoration by highly active anti-retroviral therapy comparable to non-progression? |
| Q34142433 | Changes in function of HIV-specific T-cell responses with increasing time from infection |
| Q35784804 | Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load |
| Q81366452 | Characterization of HIV-1 Gag-specific T cell responses in chronically infected Indian population |
| Q41916926 | Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages |
| Q37422520 | Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides |
| Q35212683 | Detection and enrichment of antigen-specific CD4+ and CD8+ T cells based on cytokine secretion |
| Q36474240 | Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 |
| Q35140055 | Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons |
| Q39683633 | Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication |
| Q37846864 | Dissecting the human immunologic memory for pathogens |
| Q35784244 | Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection |
| Q34498993 | Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution |
| Q34470969 | Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection |
| Q35001377 | Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses? |
| Q37705969 | Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection |
| Q36498230 | Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy |
| Q37854081 | Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). |
| Q37150560 | Expanding roles for CD4⁺ T cells in immunity to viruses. |
| Q36149329 | Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication |
| Q36154837 | Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs |
| Q36898820 | Gag-specific CD4+ T-cell frequency is inversely correlated with proviral load and directly correlated with immune activation in infection with human immunodeficiency virus type 2 (HIV-2) but not HIV-1. |
| Q40480304 | HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease. |
| Q34448446 | HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication |
| Q33958893 | HIV preferentially infects HIV-specific CD4+ T cells |
| Q36371562 | HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity |
| Q57080548 | HIV-1-Specific CD4+ T Cell Responses in Chronically HIV-1 Infected Blippers on Antiretroviral Therapy in Relation to Viral Replication Following Treatment Interruption |
| Q33731771 | HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound |
| Q37866624 | HIV-specific CD4 T cells and immune control of viral replication |
| Q43783464 | HIV-specific immunity during structured antiviral drug treatment interruption |
| Q37051248 | HLA/KIR restraint of HIV: surviving the fittest |
| Q45395724 | Human immunodeficiency virus (HIV)-specific T helper responses fail to predict CD4+ T cell decline following short-course treatment at primary HIV-1 infection |
| Q37596842 | Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels |
| Q37333793 | Human immunodeficiency virus type 1 escapes from interleukin-2-producing CD4+ T-cell responses without high-frequency fixation of mutations |
| Q51980542 | Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naïve) and CD45RO+ (memory) subsets in HIV-1-infected subjects. |
| Q37458864 | IFNγ/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children |
| Q36447548 | IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control |
| Q37199493 | Immune activation and collateral damage in AIDS pathogenesis. |
| Q40377124 | Immune deficiency in HIV-1 infection: novel therapeutic approaches targeting innate and adaptive responses |
| Q37152749 | Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients |
| Q45411590 | Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses |
| Q34033051 | Immunity to HIV in Early Life |
| Q51965254 | Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy. |
| Q33427803 | Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection |
| Q36989456 | Immunogenetics of HIV disease |
| Q33637584 | Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy |
| Q28183667 | Immunopathogenesis and immunotherapy in AIDS virus infections |
| Q56334451 | Impaired CMV Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres |
| Q27477797 | Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection |
| Q34050143 | In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection |
| Q36228123 | Induction of a virus-specific effector-memory CD4+ T cell response by attenuated SIV infection |
| Q42130441 | Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease |
| Q34159342 | Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward |
| Q24804986 | Limited durability of viral control following treated acute HIV infection |
| Q36242314 | Low frequencies of central memory CD4 T cells in progressive multifocal leukoencephalopathy |
| Q35153496 | Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects |
| Q39991596 | Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection |
| Q28484046 | Modeling of HIV-1 infection: insights to the role of monocytes/macrophages, latently infected T4 cells, and HAART regimes |
| Q64266635 | Molecular Basis of the Differentiation and Function of Virus Specific Follicular Helper CD4 T Cells |
| Q40120996 | Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status |
| Q45508924 | Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects |
| Q36720991 | Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector |
| Q37191948 | Polyfunctional CD4+ T-cell induction in neutralizing antibody-triggered control of simian immunodeficiency virus infection. |
| Q34717597 | Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo |
| Q36315197 | Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study |
| Q42109893 | Progress in defining CD4 helper cell responses in chronic viral infections |
| Q34712708 | Promises and pitfalls in the reconstitution of immunity in patients who have HIV-1 infection |
| Q24796745 | Reconsidering early HIV treatment and supervised treatment interruptions |
| Q35066683 | Recurrent community-acquired methicillin-resistant Staphylococcus aureus infections in an HIV-infected person |
| Q37700859 | Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection |
| Q35165793 | Relationship between circulating interleukin-10 and histological features in patients with chronic C hepatitis |
| Q34801866 | STI and beyond: the prospects of boosting anti-HIV immune responses |
| Q34583760 | Structured Treatment Interruption: Approaches and Risks |
| Q34550760 | T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control |
| Q30014840 | T-cell quality in memory and protection: implications for vaccine design |
| Q100456050 | The HIV-1 latent reservoir is largely sensitive to circulating T cells |
| Q74780517 | The Role of CD4(+) and CD8(+) T Cells in Controlling HIV Infection |
| Q34200151 | The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences |
| Q36142172 | The effect of declining exposure on T cell-mediated immunity to Plasmodium falciparum - an epidemiological "natural experiment". |
| Q34650563 | The infectious synapse formed between mature dendritic cells and CD4(+) T cells is independent of the presence of the HIV-1 envelope glycoprotein |
| Q90616644 | The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation |
| Q33279519 | The role of cytokines which signal through the common gamma chain cytokine receptor in the reversal of HIV specific CD4(+) and CD8(+) T cell anergy |
| Q36238709 | Therapeutic immunization strategies for the control of HIV-1. |
| Q38013505 | Therapeutic vaccines against HIV infection |
| Q81653120 | To kill or be killed: how HIV exhausts the immune system |
| Q35967372 | Use of cytokines in infection |
| Q36604777 | Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunity |
| Q36524099 | Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs |